home / stock / csbtf / csbtf short
Short Information | Kuros Biosciences Ltd (OTCMKTS:CSBTF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 29,138 |
Total Actual Volume | 49,945 |
Short Trends | |
---|---|
Cover Days | 5 |
Short Days | 14 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 1,457 |
Average Short Percentage | 71.99% |
Is there a CSBTF Short Squeeze or Breakout about to happen?
See the CSBTF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
05-02-2024 | $0 | $7.1 | $0 | $0 | 2 | 2 | 100% |
04-30-2024 | $6.94 | $7.1 | $7.1 | $6.94 | 1,750 | 750 | 42.86% |
04-29-2024 | $7.1 | $7.1 | $7.1 | $7.1 | 421 | 21 | 4.99% |
04-25-2024 | $0 | $9.05 | $0 | $0 | 19 | 19 | 100% |
04-22-2024 | $8.69 | $9.05 | $9.05 | $8.69 | 2,000 | 1,844 | 92.2% |
04-19-2024 | $8.62 | $8.35 | $8.89 | $8.35 | 2,400 | 2,400 | 100% |
04-16-2024 | $7.965 | $7.965 | $7.965 | $7.965 | 100 | 100 | 100% |
04-12-2024 | $8.69 | $8.69 | $8.69 | $8.69 | 100 | 100 | 100% |
04-10-2024 | $7.56 | $7.9 | $8.09 | $7.56 | 3,601 | 850 | 23.6% |
04-08-2024 | $6.8 | $6.695 | $6.9 | $6.695 | 2,457 | 157 | 6.39% |
04-03-2024 | $6.55 | $6.55 | $6.55 | $6.55 | 1,000 | 1,000 | 100% |
04-02-2024 | $6.55 | $6.55 | $6.55 | $6.55 | 1,000 | 1,000 | 100% |
04-01-2024 | $6.55 | $6.4 | $6.55 | $6.37 | 4,100 | 1,100 | 26.83% |
03-28-2024 | $6.65 | $6.3 | $6.65 | $6.3 | 25,518 | 15,518 | 60.81% |
03-26-2024 | $6.25 | $6.25 | $6.25 | $6.25 | 3,000 | 3,000 | 100% |
03-25-2024 | $6.15 | $6.25 | $6.25 | $6.15 | 1,300 | 200 | 15.38% |
03-15-2024 | $0 | $6 | $0 | $0 | 50 | 50 | 100% |
03-13-2024 | $6.3 | $6 | $6.3 | $6 | 300 | 200 | 66.67% |
03-12-2024 | $6.29 | $6.3 | $6.3 | $6.25 | 622 | 622 | 100% |
03-11-2024 | $6.015 | $6.015 | $6.015 | $6.015 | 205 | 205 | 100% |
News, Short Squeeze, Breakout and More Instantly...
Kuros Biosciences Ltd Company Name:
CSBTF Stock Symbol:
OTCMKTS Market:
Financial Highlights Direct MagnetOs sales rose by 155% to CHF 13.9 million in Q1 2024 from CHF 5.4 million in Q1 2023; this corresponds to a sequential increase of 21.9% or CHF 2.5 million over Q4 2023 Total Kuros Medical Devices segment sales accelerated to CHF 13.9 million in Q1 202...
ZURICH, SWITZERLAND / ACCESSWIRE / April 17, 2024 / Kuros Biosciences (SIX:KURN), a leader in next generation bone graft technologies, held its Annual General Meeting today. The Annual General Meeting approved the Annual Report, the Annual Financial Statements, and the Consolidated Financial St...
Financial highlights Direct MagnetOs sales grew by 163% to CHF 31.7 million in 2023, climbing from CHF 12.1 million in 2022. Total medical device sales accelerated by 153% from CHF 13.3 million in 2022 to CHF 33.6 million in 2023 The Medical Devices segment achieved a positive EBITDA o...